Issues regarding approved and pipeline products, and related policy. 340 program issues.
2026 · 3rd Quarter (July 1 - Sep 30)
BRISTOL-MYERS SQUIBB
Filed by CAPITOL COUNSEL LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- CAPITOL COUNSEL LLC
- Client
- BRISTOL-MYERS SQUIBB
- Filing UUID
- caa8367a-ba15-4482-b2cf-44ef674a4411
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues regarding approved and pipeline products, and related policy. FDA Clinical Trial reform proposals.
Issues regarding approved and pipeline products, and related policy. IRA price negotiation. MFN proposals, including GLOBE and GUARD and impacts on innovation.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.